<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2025, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 23 Jun 2025 18:42:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>GENOMMA LAB INTERNACIONAL ANNOUNCES TWELFTH DIVIDEND PAYMENT</title>
   <link>http://www.streetinsider.com/Press+Releases/GENOMMA+LAB+INTERNACIONAL+ANNOUNCES+TWELFTH+DIVIDEND+PAYMENT/24966341.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 23, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;.&lt;/b&gt; &lt;b&gt;(BMV: LABB)&lt;/b&gt; (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of the leading pharmaceutical and personal care product companies in &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico&lt;/location&gt; with an expanding international presence, informs that the Company filed a Notice of Rights with the &lt;span&gt;Mexican Stock Exchange&lt;/span&gt; (Bolsa &lt;person&gt;Mexicana de Valores&lt;/person&gt;) declaring a cash dividend of &lt;b&gt;&lt;money&gt;$0.200000&lt;/money&gt;&lt;/b&gt; Mexican pesos per share on its common stock representing a total amount of &lt;b&gt;&lt;money&gt;$200,000,000.00&lt;/money&gt; M.N.&lt;/b&gt; (two hundred million &lt;money&gt;pesos 00/100&lt;/money&gt; National Currency), payable to shareholders of record of the applicable</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/GENOMMA+LAB+INTERNACIONAL+ANNOUNCES+TWELFTH+DIVIDEND+PAYMENT/24966341.html</guid>
   <pubDate>Mon, 23 Jun 2025 18:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>GENOMMA LAB INTERNACIONAL ANNOUNCES TWELFTH DIVIDEND PAYMENT</title>
   <link>http://www.streetinsider.com/Press+Releases/GENOMMA+LAB+INTERNACIONAL+ANNOUNCES+TWELFTH+DIVIDEND+PAYMENT/24966341.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 23, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;.&lt;/b&gt; &lt;b&gt;(BMV: LABB)&lt;/b&gt; (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of the leading pharmaceutical and personal care product companies in &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico&lt;/location&gt; with an expanding international presence, informs that the Company filed a Notice of Rights with the &lt;span&gt;Mexican Stock Exchange&lt;/span&gt; (Bolsa &lt;person&gt;Mexicana de Valores&lt;/person&gt;) declaring a cash dividend of &lt;b&gt;&lt;money&gt;$0.200000&lt;/money&gt;&lt;/b&gt; Mexican pesos per share on its common stock representing a total amount of &lt;b&gt;&lt;money&gt;$200,000,000.00&lt;/money&gt; M.N.&lt;/b&gt; (two hundred million &lt;money&gt;pesos 00/100&lt;/money&gt; National Currency), payable to shareholders of record of the applicable</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/GENOMMA+LAB+INTERNACIONAL+ANNOUNCES+TWELFTH+DIVIDEND+PAYMENT/24966341.html</guid>
   <pubDate>Mon, 23 Jun 2025 18:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>GENOMMA LAB INTERNACIONAL ANNOUNCES TWELFTH DIVIDEND PAYMENT</title>
   <link>http://www.streetinsider.com/PRNewswire/GENOMMA+LAB+INTERNACIONAL+ANNOUNCES+TWELFTH+DIVIDEND+PAYMENT/24966341.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 23, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;.&lt;/b&gt; &lt;b&gt;(BMV: LABB)&lt;/b&gt; (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of the leading pharmaceutical and personal care product companies in &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico&lt;/location&gt; with an expanding international presence, informs that the Company filed a Notice of Rights with the &lt;span&gt;Mexican Stock Exchange&lt;/span&gt; (Bolsa &lt;person&gt;Mexicana de Valores&lt;/person&gt;) declaring a cash dividend of &lt;b&gt;&lt;money&gt;$0.200000&lt;/money&gt;&lt;/b&gt; Mexican pesos per share on its common stock representing a total amount of &lt;b&gt;&lt;money&gt;$200,000,000.00&lt;/money&gt; M.N.&lt;/b&gt; (two hundred million &lt;money&gt;pesos 00/100&lt;/money&gt; National Currency), payable to shareholders of record of the applicable</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/GENOMMA+LAB+INTERNACIONAL+ANNOUNCES+TWELFTH+DIVIDEND+PAYMENT/24966341.html</guid>
   <pubDate>Mon, 23 Jun 2025 18:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>GENOMMA LAB INTERNACIONAL ANNOUNCES TWELFTH DIVIDEND PAYMENT</title>
   <link>http://www.streetinsider.com/PRNewswire/GENOMMA+LAB+INTERNACIONAL+ANNOUNCES+TWELFTH+DIVIDEND+PAYMENT/24966341.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 23, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;.&lt;/b&gt; &lt;b&gt;(BMV: LABB)&lt;/b&gt; (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of the leading pharmaceutical and personal care product companies in &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico&lt;/location&gt; with an expanding international presence, informs that the Company filed a Notice of Rights with the &lt;span&gt;Mexican Stock Exchange&lt;/span&gt; (Bolsa &lt;person&gt;Mexicana de Valores&lt;/person&gt;) declaring a cash dividend of &lt;b&gt;&lt;money&gt;$0.200000&lt;/money&gt;&lt;/b&gt; Mexican pesos per share on its common stock representing a total amount of &lt;b&gt;&lt;money&gt;$200,000,000.00&lt;/money&gt; M.N.&lt;/b&gt; (two hundred million &lt;money&gt;pesos 00/100&lt;/money&gt; National Currency), payable to shareholders of record of the applicable</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/GENOMMA+LAB+INTERNACIONAL+ANNOUNCES+TWELFTH+DIVIDEND+PAYMENT/24966341.html</guid>
   <pubDate>Mon, 23 Jun 2025 18:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>GENOMMA LAB INTERNATIONAL INFORMS TOTAL PREPAYMENT OF &amp;quot;LAB 23&amp;quot; UNSECURED LOCAL BOND (CEBUR)</title>
   <link>http://www.streetinsider.com/Press+Releases/GENOMMA+LAB+INTERNATIONAL+INFORMS+TOTAL+PREPAYMENT+OF+%26quot%3BLAB+23%26quot%3B+UNSECURED+LOCAL+BOND+%28CEBUR%29/24929844.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 12, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- Genomma Lab Internacional, &lt;span&gt;S.A.B. de C.V.&lt;/span&gt; (BMV: LABB) (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico's&lt;/location&gt; leading pharmaceutical and personal care companies with a growing international footprint, announced that on &lt;chron&gt;June 11, 2025&lt;/chron&gt;, it completed the full early amortization of its debt certificates listed under the ticker symbol &quot;LAB 23.&quot;&lt;/p&gt;

&lt;p&gt;The transaction amounted to more than MXN 1,000 million, covering both principal and accrued interest to date. In addition, the Company also made an early repayment of MXN 400 million in bank debt.&lt;/p&gt;
&lt;p&gt;&lt;person&gt;Antonio Zamora Galland&lt;/person&gt;, Chief</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/GENOMMA+LAB+INTERNATIONAL+INFORMS+TOTAL+PREPAYMENT+OF+%26quot%3BLAB+23%26quot%3B+UNSECURED+LOCAL+BOND+%28CEBUR%29/24929844.html</guid>
   <pubDate>Thu, 12 Jun 2025 11:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>GENOMMA LAB INTERNATIONAL INFORMS TOTAL PREPAYMENT OF &amp;quot;LAB 23&amp;quot; UNSECURED LOCAL BOND (CEBUR)</title>
   <link>http://www.streetinsider.com/Press+Releases/GENOMMA+LAB+INTERNATIONAL+INFORMS+TOTAL+PREPAYMENT+OF+%26quot%3BLAB+23%26quot%3B+UNSECURED+LOCAL+BOND+%28CEBUR%29/24929844.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 12, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- Genomma Lab Internacional, &lt;span&gt;S.A.B. de C.V.&lt;/span&gt; (BMV: LABB) (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico's&lt;/location&gt; leading pharmaceutical and personal care companies with a growing international footprint, announced that on &lt;chron&gt;June 11, 2025&lt;/chron&gt;, it completed the full early amortization of its debt certificates listed under the ticker symbol &quot;LAB 23.&quot;&lt;/p&gt;

&lt;p&gt;The transaction amounted to more than MXN 1,000 million, covering both principal and accrued interest to date. In addition, the Company also made an early repayment of MXN 400 million in bank debt.&lt;/p&gt;
&lt;p&gt;&lt;person&gt;Antonio Zamora Galland&lt;/person&gt;, Chief</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/GENOMMA+LAB+INTERNATIONAL+INFORMS+TOTAL+PREPAYMENT+OF+%26quot%3BLAB+23%26quot%3B+UNSECURED+LOCAL+BOND+%28CEBUR%29/24929844.html</guid>
   <pubDate>Thu, 12 Jun 2025 11:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>GENOMMA LAB INTERNATIONAL INFORMS TOTAL PREPAYMENT OF &amp;quot;LAB 23&amp;quot; UNSECURED LOCAL BOND (CEBUR)</title>
   <link>http://www.streetinsider.com/PRNewswire/GENOMMA+LAB+INTERNATIONAL+INFORMS+TOTAL+PREPAYMENT+OF+%26quot%3BLAB+23%26quot%3B+UNSECURED+LOCAL+BOND+%28CEBUR%29/24929844.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 12, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- Genomma Lab Internacional, &lt;span&gt;S.A.B. de C.V.&lt;/span&gt; (BMV: LABB) (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico's&lt;/location&gt; leading pharmaceutical and personal care companies with a growing international footprint, announced that on &lt;chron&gt;June 11, 2025&lt;/chron&gt;, it completed the full early amortization of its debt certificates listed under the ticker symbol &quot;LAB 23.&quot;&lt;/p&gt;

&lt;p&gt;The transaction amounted to more than MXN 1,000 million, covering both principal and accrued interest to date. In addition, the Company also made an early repayment of MXN 400 million in bank debt.&lt;/p&gt;
&lt;p&gt;&lt;person&gt;Antonio Zamora Galland&lt;/person&gt;, Chief</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/GENOMMA+LAB+INTERNATIONAL+INFORMS+TOTAL+PREPAYMENT+OF+%26quot%3BLAB+23%26quot%3B+UNSECURED+LOCAL+BOND+%28CEBUR%29/24929844.html</guid>
   <pubDate>Thu, 12 Jun 2025 11:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>GENOMMA LAB INTERNATIONAL INFORMS TOTAL PREPAYMENT OF &amp;quot;LAB 23&amp;quot; UNSECURED LOCAL BOND (CEBUR)</title>
   <link>http://www.streetinsider.com/PRNewswire/GENOMMA+LAB+INTERNATIONAL+INFORMS+TOTAL+PREPAYMENT+OF+%26quot%3BLAB+23%26quot%3B+UNSECURED+LOCAL+BOND+%28CEBUR%29/24929844.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 12, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- Genomma Lab Internacional, &lt;span&gt;S.A.B. de C.V.&lt;/span&gt; (BMV: LABB) (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico's&lt;/location&gt; leading pharmaceutical and personal care companies with a growing international footprint, announced that on &lt;chron&gt;June 11, 2025&lt;/chron&gt;, it completed the full early amortization of its debt certificates listed under the ticker symbol &quot;LAB 23.&quot;&lt;/p&gt;

&lt;p&gt;The transaction amounted to more than MXN 1,000 million, covering both principal and accrued interest to date. In addition, the Company also made an early repayment of MXN 400 million in bank debt.&lt;/p&gt;
&lt;p&gt;&lt;person&gt;Antonio Zamora Galland&lt;/person&gt;, Chief</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/GENOMMA+LAB+INTERNATIONAL+INFORMS+TOTAL+PREPAYMENT+OF+%26quot%3BLAB+23%26quot%3B+UNSECURED+LOCAL+BOND+%28CEBUR%29/24929844.html</guid>
   <pubDate>Thu, 12 Jun 2025 11:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortizat</title>
   <link>http://www.streetinsider.com/Press+Releases/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p class=&quot;prntac&quot;&gt;&lt;b&gt;The 6- and 7-year tranches were oversubscribed by 1.25 times the total amount offered&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 4, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;.&lt;/b&gt; (BMV: LABB) (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of the leading pharmaceutical and personal care product companies in &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico&lt;/location&gt; with an expanding international presence, announces the successful placement of unsecured Mexican corporate bonds (&lt;i&gt;Cebures&lt;/i&gt;) for a total amount of MXN &lt;money&gt;$1,200,000,000.00&lt;/money&gt; (One billion two hundred million &lt;money&gt;pesos 00/100&lt;/money&gt; M.N.).&lt;/p&gt;

&lt;p&gt;The LAB 25 and LAB 25-2 transactions were placed among a diversified base of investors, with demand</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</guid>
   <pubDate>Wed, 04 Jun 2025 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.24889453</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05009076</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortizat</title>
   <link>http://www.streetinsider.com/Press+Releases/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p class=&quot;prntac&quot;&gt;&lt;b&gt;The 6- and 7-year tranches were oversubscribed by 1.25 times the total amount offered&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 4, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;.&lt;/b&gt; (BMV: LABB) (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of the leading pharmaceutical and personal care product companies in &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico&lt;/location&gt; with an expanding international presence, announces the successful placement of unsecured Mexican corporate bonds (&lt;i&gt;Cebures&lt;/i&gt;) for a total amount of MXN &lt;money&gt;$1,200,000,000.00&lt;/money&gt; (One billion two hundred million &lt;money&gt;pesos 00/100&lt;/money&gt; M.N.).&lt;/p&gt;

&lt;p&gt;The LAB 25 and LAB 25-2 transactions were placed among a diversified base of investors, with demand</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</guid>
   <pubDate>Wed, 04 Jun 2025 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.24889453</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05009076</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortizat</title>
   <link>http://www.streetinsider.com/Press+Releases/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p class=&quot;prntac&quot;&gt;&lt;b&gt;The 6- and 7-year tranches were oversubscribed by 1.25 times the total amount offered&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 4, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;.&lt;/b&gt; (BMV: LABB) (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of the leading pharmaceutical and personal care product companies in &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico&lt;/location&gt; with an expanding international presence, announces the successful placement of unsecured Mexican corporate bonds (&lt;i&gt;Cebures&lt;/i&gt;) for a total amount of MXN &lt;money&gt;$1,200,000,000.00&lt;/money&gt; (One billion two hundred million &lt;money&gt;pesos 00/100&lt;/money&gt; M.N.).&lt;/p&gt;

&lt;p&gt;The LAB 25 and LAB 25-2 transactions were placed among a diversified base of investors, with demand</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</guid>
   <pubDate>Wed, 04 Jun 2025 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.24889453</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05009076</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortizat</title>
   <link>http://www.streetinsider.com/Press+Releases/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p class=&quot;prntac&quot;&gt;&lt;b&gt;The 6- and 7-year tranches were oversubscribed by 1.25 times the total amount offered&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 4, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;.&lt;/b&gt; (BMV: LABB) (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of the leading pharmaceutical and personal care product companies in &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico&lt;/location&gt; with an expanding international presence, announces the successful placement of unsecured Mexican corporate bonds (&lt;i&gt;Cebures&lt;/i&gt;) for a total amount of MXN &lt;money&gt;$1,200,000,000.00&lt;/money&gt; (One billion two hundred million &lt;money&gt;pesos 00/100&lt;/money&gt; M.N.).&lt;/p&gt;

&lt;p&gt;The LAB 25 and LAB 25-2 transactions were placed among a diversified base of investors, with demand</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</guid>
   <pubDate>Wed, 04 Jun 2025 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.24889453</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05009076</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortizat</title>
   <link>http://www.streetinsider.com/PRNewswire/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p class=&quot;prntac&quot;&gt;&lt;b&gt;The 6- and 7-year tranches were oversubscribed by 1.25 times the total amount offered&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 4, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;.&lt;/b&gt; (BMV: LABB) (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of the leading pharmaceutical and personal care product companies in &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico&lt;/location&gt; with an expanding international presence, announces the successful placement of unsecured Mexican corporate bonds (&lt;i&gt;Cebures&lt;/i&gt;) for a total amount of MXN &lt;money&gt;$1,200,000,000.00&lt;/money&gt; (One billion two hundred million &lt;money&gt;pesos 00/100&lt;/money&gt; M.N.).&lt;/p&gt;

&lt;p&gt;The LAB 25 and LAB 25-2 transactions were placed among a diversified base of investors, with demand</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</guid>
   <pubDate>Wed, 04 Jun 2025 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.24889453</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05009076</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortizat</title>
   <link>http://www.streetinsider.com/PRNewswire/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p class=&quot;prntac&quot;&gt;&lt;b&gt;The 6- and 7-year tranches were oversubscribed by 1.25 times the total amount offered&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 4, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;.&lt;/b&gt; (BMV: LABB) (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of the leading pharmaceutical and personal care product companies in &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico&lt;/location&gt; with an expanding international presence, announces the successful placement of unsecured Mexican corporate bonds (&lt;i&gt;Cebures&lt;/i&gt;) for a total amount of MXN &lt;money&gt;$1,200,000,000.00&lt;/money&gt; (One billion two hundred million &lt;money&gt;pesos 00/100&lt;/money&gt; M.N.).&lt;/p&gt;

&lt;p&gt;The LAB 25 and LAB 25-2 transactions were placed among a diversified base of investors, with demand</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</guid>
   <pubDate>Wed, 04 Jun 2025 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.24889453</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05009076</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortizat</title>
   <link>http://www.streetinsider.com/PRNewswire/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p class=&quot;prntac&quot;&gt;&lt;b&gt;The 6- and 7-year tranches were oversubscribed by 1.25 times the total amount offered&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 4, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;.&lt;/b&gt; (BMV: LABB) (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of the leading pharmaceutical and personal care product companies in &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico&lt;/location&gt; with an expanding international presence, announces the successful placement of unsecured Mexican corporate bonds (&lt;i&gt;Cebures&lt;/i&gt;) for a total amount of MXN &lt;money&gt;$1,200,000,000.00&lt;/money&gt; (One billion two hundred million &lt;money&gt;pesos 00/100&lt;/money&gt; M.N.).&lt;/p&gt;

&lt;p&gt;The LAB 25 and LAB 25-2 transactions were placed among a diversified base of investors, with demand</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</guid>
   <pubDate>Wed, 04 Jun 2025 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.24889453</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05009076</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortizat</title>
   <link>http://www.streetinsider.com/PRNewswire/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p class=&quot;prntac&quot;&gt;&lt;b&gt;The 6- and 7-year tranches were oversubscribed by 1.25 times the total amount offered&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 4, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;.&lt;/b&gt; (BMV: LABB) (&quot;&lt;span&gt;Genomma Lab&lt;/span&gt;&quot; or &quot;the Company&quot;), one of the leading pharmaceutical and personal care product companies in &lt;location value=&quot;LC/mx&quot; idsrc=&quot;xmltag.org&quot; &gt;Mexico&lt;/location&gt; with an expanding international presence, announces the successful placement of unsecured Mexican corporate bonds (&lt;i&gt;Cebures&lt;/i&gt;) for a total amount of MXN &lt;money&gt;$1,200,000,000.00&lt;/money&gt; (One billion two hundred million &lt;money&gt;pesos 00/100&lt;/money&gt; M.N.).&lt;/p&gt;

&lt;p&gt;The LAB 25 and LAB 25-2 transactions were placed among a diversified base of investors, with demand</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Genomma+Lab+successfully+issued+the+LAB+25+and+LAB+25-2+unsecured+bonds+%28Cebures%29+for+a+total+amount+of+%241.2+billion+pesos%2C+which+will+be+used+to+prepay+liabilities%2C+including+the+full+early+amortizat/24896361.html</guid>
   <pubDate>Wed, 04 Jun 2025 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.24889453</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05009076</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab Internacional Announces Results for the First Quarter 2025</title>
   <link>http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;April 30, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;. &lt;/b&gt;(BMV: LAB B) (&quot;Genomma&quot; or &quot;the Company&quot;), today announced its results for the first quarter of 2025. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned.&lt;/p&gt;

&lt;p&gt;&lt;b&gt;Comments from Genomma's CEO, &lt;person&gt;Marco Sparvieri&lt;/person&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;i&gt;&quot;Genomma sales grew 5.0% in Q1 2025 while sell-out grew in the low teens. The sell-in / sell-out gap is mainly due to the &lt;location value=&quot;LC/us&quot; idsrc=&quot;xmltag.org&quot; &gt;U.S.&lt;/location&gt; and &lt;location value=&quot;LC/ar&quot; idsrc=&quot;xmltag.org&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</guid>
   <pubDate>Wed, 30 Apr 2025 18:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09299769</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24817021</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202530</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LAB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02698458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05024708</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab Internacional Announces Results for the First Quarter 2025</title>
   <link>http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;April 30, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;. &lt;/b&gt;(BMV: LAB B) (&quot;Genomma&quot; or &quot;the Company&quot;), today announced its results for the first quarter of 2025. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned.&lt;/p&gt;

&lt;p&gt;&lt;b&gt;Comments from Genomma's CEO, &lt;person&gt;Marco Sparvieri&lt;/person&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;i&gt;&quot;Genomma sales grew 5.0% in Q1 2025 while sell-out grew in the low teens. The sell-in / sell-out gap is mainly due to the &lt;location value=&quot;LC/us&quot; idsrc=&quot;xmltag.org&quot; &gt;U.S.&lt;/location&gt; and &lt;location value=&quot;LC/ar&quot; idsrc=&quot;xmltag.org&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</guid>
   <pubDate>Wed, 30 Apr 2025 18:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09299769</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24817021</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202530</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LAB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02698458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05024708</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab Internacional Announces Results for the First Quarter 2025</title>
   <link>http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;April 30, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;. &lt;/b&gt;(BMV: LAB B) (&quot;Genomma&quot; or &quot;the Company&quot;), today announced its results for the first quarter of 2025. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned.&lt;/p&gt;

&lt;p&gt;&lt;b&gt;Comments from Genomma's CEO, &lt;person&gt;Marco Sparvieri&lt;/person&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;i&gt;&quot;Genomma sales grew 5.0% in Q1 2025 while sell-out grew in the low teens. The sell-in / sell-out gap is mainly due to the &lt;location value=&quot;LC/us&quot; idsrc=&quot;xmltag.org&quot; &gt;U.S.&lt;/location&gt; and &lt;location value=&quot;LC/ar&quot; idsrc=&quot;xmltag.org&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</guid>
   <pubDate>Wed, 30 Apr 2025 18:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09299769</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24817021</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202530</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LAB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02698458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05024708</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab Internacional Announces Results for the First Quarter 2025</title>
   <link>http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;April 30, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;. &lt;/b&gt;(BMV: LAB B) (&quot;Genomma&quot; or &quot;the Company&quot;), today announced its results for the first quarter of 2025. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned.&lt;/p&gt;

&lt;p&gt;&lt;b&gt;Comments from Genomma's CEO, &lt;person&gt;Marco Sparvieri&lt;/person&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;i&gt;&quot;Genomma sales grew 5.0% in Q1 2025 while sell-out grew in the low teens. The sell-in / sell-out gap is mainly due to the &lt;location value=&quot;LC/us&quot; idsrc=&quot;xmltag.org&quot; &gt;U.S.&lt;/location&gt; and &lt;location value=&quot;LC/ar&quot; idsrc=&quot;xmltag.org&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</guid>
   <pubDate>Wed, 30 Apr 2025 18:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09299769</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24817021</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202530</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LAB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02698458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05024708</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab Internacional Announces Results for the First Quarter 2025</title>
   <link>http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;April 30, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;. &lt;/b&gt;(BMV: LAB B) (&quot;Genomma&quot; or &quot;the Company&quot;), today announced its results for the first quarter of 2025. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned.&lt;/p&gt;

&lt;p&gt;&lt;b&gt;Comments from Genomma's CEO, &lt;person&gt;Marco Sparvieri&lt;/person&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;i&gt;&quot;Genomma sales grew 5.0% in Q1 2025 while sell-out grew in the low teens. The sell-in / sell-out gap is mainly due to the &lt;location value=&quot;LC/us&quot; idsrc=&quot;xmltag.org&quot; &gt;U.S.&lt;/location&gt; and &lt;location value=&quot;LC/ar&quot; idsrc=&quot;xmltag.org&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</guid>
   <pubDate>Wed, 30 Apr 2025 18:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09299769</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24817021</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202530</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LAB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02698458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05024708</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab Internacional Announces Results for the First Quarter 2025</title>
   <link>http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;April 30, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;. &lt;/b&gt;(BMV: LAB B) (&quot;Genomma&quot; or &quot;the Company&quot;), today announced its results for the first quarter of 2025. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned.&lt;/p&gt;

&lt;p&gt;&lt;b&gt;Comments from Genomma's CEO, &lt;person&gt;Marco Sparvieri&lt;/person&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;i&gt;&quot;Genomma sales grew 5.0% in Q1 2025 while sell-out grew in the low teens. The sell-in / sell-out gap is mainly due to the &lt;location value=&quot;LC/us&quot; idsrc=&quot;xmltag.org&quot; &gt;U.S.&lt;/location&gt; and &lt;location value=&quot;LC/ar&quot; idsrc=&quot;xmltag.org&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</guid>
   <pubDate>Wed, 30 Apr 2025 18:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09299769</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24817021</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202530</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LAB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02698458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05024708</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab Internacional Announces Results for the First Quarter 2025</title>
   <link>http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;April 30, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;. &lt;/b&gt;(BMV: LAB B) (&quot;Genomma&quot; or &quot;the Company&quot;), today announced its results for the first quarter of 2025. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned.&lt;/p&gt;

&lt;p&gt;&lt;b&gt;Comments from Genomma's CEO, &lt;person&gt;Marco Sparvieri&lt;/person&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;i&gt;&quot;Genomma sales grew 5.0% in Q1 2025 while sell-out grew in the low teens. The sell-in / sell-out gap is mainly due to the &lt;location value=&quot;LC/us&quot; idsrc=&quot;xmltag.org&quot; &gt;U.S.&lt;/location&gt; and &lt;location value=&quot;LC/ar&quot; idsrc=&quot;xmltag.org&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</guid>
   <pubDate>Wed, 30 Apr 2025 18:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09299769</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24817021</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202530</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LAB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02698458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05024708</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab Internacional Announces Results for the First Quarter 2025</title>
   <link>http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;April 30, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;. &lt;/b&gt;(BMV: LAB B) (&quot;Genomma&quot; or &quot;the Company&quot;), today announced its results for the first quarter of 2025. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned.&lt;/p&gt;

&lt;p&gt;&lt;b&gt;Comments from Genomma's CEO, &lt;person&gt;Marco Sparvieri&lt;/person&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;i&gt;&quot;Genomma sales grew 5.0% in Q1 2025 while sell-out grew in the low teens. The sell-in / sell-out gap is mainly due to the &lt;location value=&quot;LC/us&quot; idsrc=&quot;xmltag.org&quot; &gt;U.S.&lt;/location&gt; and &lt;location value=&quot;LC/ar&quot; idsrc=&quot;xmltag.org&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</guid>
   <pubDate>Wed, 30 Apr 2025 18:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09299769</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24817021</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202530</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LAB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02698458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05024708</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
  <item>
   <title>Genomma Lab Internacional Announces Results for the First Quarter 2025</title>
   <link>http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/mx.sm.mexcty&quot; idsrc=&quot;xmltag.org&quot; &gt;MEXICO CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;April 30, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;span value=&quot;Mexico:LABB&quot; idsrc=&quot;xmltag.org&quot; &gt;Genomma Lab Internacional, S.A.B. de C.V&lt;/span&gt;. &lt;/b&gt;(BMV: LAB B) (&quot;Genomma&quot; or &quot;the Company&quot;), today announced its results for the first quarter of 2025. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned.&lt;/p&gt;

&lt;p&gt;&lt;b&gt;Comments from Genomma's CEO, &lt;person&gt;Marco Sparvieri&lt;/person&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;i&gt;&quot;Genomma sales grew 5.0% in Q1 2025 while sell-out grew in the low teens. The sell-in / sell-out gap is mainly due to the &lt;location value=&quot;LC/us&quot; idsrc=&quot;xmltag.org&quot; &gt;U.S.&lt;/location&gt; and &lt;location value=&quot;LC/ar&quot; idsrc=&quot;xmltag.org&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Genomma+Lab+Internacional+Announces+Results+for+the+First+Quarter+2025/24720562.html</guid>
   <pubDate>Wed, 30 Apr 2025 18:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09299769</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24817021</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202530</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LAB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LABB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02698458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05024708</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14362265</category>
   	  </item>
 </channel>
</rss>
